In vivo antimalarial action of a lipophilic iron (III) chelator: Suppression of plasmodium vinckei infection by reversed siderophore
暂无分享,去创建一个
B. Mester | J. Libman | A. Shanzer | Z. Cabantchik | S. Lytton | M. Loyevsky | I. Landau
[1] S. Lytton,et al. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. , 1993, The Journal of clinical investigation.
[2] S. Lytton,et al. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity. , 1993, Blood.
[3] S. Lytton,et al. Monitoring of iron(III) removal from biological sources using a fluorescent siderophore. , 1992, Analytical biochemistry.
[4] S. Lytton,et al. Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal. , 1991, Molecular pharmacology.
[5] S. Lytton,et al. Reversed siderophores act as antimalarial agents. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Labie,et al. Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria , 1991, American journal of hematology.
[7] P. Dobbin,et al. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. , 1991, Blood.
[8] H. Ginsburg,et al. Chronotherapy of malaria: an approach to malaria chemotherapy. , 1991, Parasitology today.
[9] T. Peto,et al. Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro. , 1990, Blood.
[10] J. Hazell,et al. Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage , 1989, British journal of haematology.
[11] J. Porter. Oral iron chelators: Prospects for future development , 1989, European journal of haematology.
[12] R. Nicolosi,et al. A non‐human primate model for the study of oral iron chelators , 1989, British journal of haematology.
[13] L. Scheibel,et al. Antimalarial activity of selected aromatic chelators V. Localization of 59Fe in Plasmodium falciparum in the presence of oxines. , 1989, Progress in clinical and biological research.
[14] J. Libman,et al. Synthetic ferrichrome analogues with growth promotion activity for Arthrobacter flavescens. , 1988, Biochemical and biophysical research communications.
[15] D. Mazier,et al. Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria. , 1988, The American journal of tropical medicine and hygiene.
[16] J. Eaton,et al. Antimalarial properties of orally active iron chelators , 1988 .
[17] T. Peto,et al. Deferoxamine inhibition of malaria is independent of host iron status , 1988, The Journal of experimental medicine.
[18] D. Weatherall,et al. Iron-chelating therapy. , 1988, Critical reviews in clinical laboratory sciences.
[19] R. Rossan,et al. Desferrioxamine Suppresses Plasmodium falciparum in Aotus Monkeys 1 , 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[20] D. Spira,et al. Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. , 1985, Experimental parasitology.
[21] R. Nagel,et al. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. , 1982, The American journal of tropical medicine and hygiene.
[22] J. Graziano,et al. Rhodotorulic acid--investigation of its potential as an iron-chelating drug. , 1979, The Journal of pharmacology and experimental therapeutics.